Clinical Trials Logo
  1. Home
  2. Hypercholesteremia
  3. NCT00688454
  4. Details
NCT00688454 Clinical Trial

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Hypercholesteremia Clinical Trial

Official title:
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00688454
Other study ID # NIS-CCH-CRE-2007/1
Secondary ID
Status Completed
Phase N/A
First received May 29, 2008
Last updated April 8, 2009
Start date February 2007
Est. completion date January 2008

Study information
Verified date April 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Observational

Clinical Trial Summary

The study explores efficacy and safety of the lipid-lowering therapy with CRESTOR in statin-naive patients and in patients with previously unsuccessful statin therapy. This study was designed to investigate the dynamic of the lipid parameters and therapy tolerability during 8-10 weeks treatment with CRESTOR

Recruitment information / eligibility
Status Completed
Enrollment 3392
Est. completion date January 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with hypercholesteremia who was never treated with statins before

- Patient with hypercholesteremia who was treated with a statin (other then rosuvastatin) but because of its adverse effects/insufficient action was switched to therapy with CRESTOR

Exclusion Criteria:

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Outcome
Type Measure Description Time frame Safety issue
Primary LDL-Cholesterin, HDL-Cholesterin, Triglycerides, Total Cholesterin 3 visits within 10 weeks No
Secondary Tolerability of CRESTOR-therapy 3 visits within 10 weeks No
See also
  Status Clinical Trial Phase
Completed NCT05164185 - The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia N/A
Completed NCT00329160 - Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease Phase 4
Completed NCT02634151 - A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins Phase 2
Completed NCT02587416 - Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers Phase 1
Completed NCT00153738 - Phytosterol Supplementation and Cardiovascular Risk N/A
Completed NCT02722408 - Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1) Phase 2
Completed NCT00239330 - Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy Phase 3
Recruiting NCT01890889 - Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health N/A
Completed NCT00376584 - Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) Phase 3
Completed NCT01477944 - Pattern of Statins Use in Catalonia N/A
Completed NCT00347217 - Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event Phase 4
Completed NCT01354327 - Effects of Limicol on LDL-cholesterol N/A
Completed NCT03634436 - The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects Phase 1
Completed NCT00225589 - A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) Phase 3
Completed NCT02850224 - Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes N/A
Completed NCT00408382 - Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque Phase 4